 Protecting the Health of Future Generations
FDA closely monitors retailer, manufacturer, importer, and distributor compliance with federal tobacco laws and regulations and takes corrective action when violations occur.
FDA takes a three-pronged approach to help industry comply with the law by:
- Developing and providing compliance training and education
- Monitoring regulated industry's compliance with the law through surveillance, inspections, and investigations
- Taking action when necessary, including:
- Warning Letters
- Civil Money Penalty (CMP) Complaints
- No-Tobacco-Sale Order (NTSO) Complaints
- Seizures, Injunctions, and Criminal Prosecution
FDA Conducts Retailer Inspections, Cracks Down on Illegal Sales of Popular Disposable E-Cigarettes
In May, FDA issued warning letters to 30 retailers, including one distributor, for illegally selling unauthorized tobacco products. The unauthorized products were various types of Puff and Hyde brand disposable e-cigarettes, which were two of the most commonly reported brands used by youth e-cigarette users in 2022. The Puff products include Puff Bar.
This action underscores the agency’s unwavering commitment to addressing the role retailers and distributors of unauthorized tobacco products play in this concerning public health issue facing today’s youth.
FDA Puts Firms Responsible for Esco Bars and Breeze—Two Popular Disposable E-Cigarette Brands—on Notice
In May, FDA issued warning letters to firms responsible for two popular flavored, disposable e-cigarette products—Shenzen Innokin Technology Co. Ltd. who make Esco Bars products and Breeze Smoke, LLC who import and distribute Breeze products. These firms have been manufacturing, distributing, and/or importing unauthorized tobacco products in the United States.
“The science clearly shows that a majority of youth who use e-cigarettes report that the products they are using are disposable and flavored,” said Brian King, Ph.D., M.P.H., director of the FDA’s Center for Tobacco Products. “Given their appeal to youth, these products are a priority for FDA compliance and enforcement action.”
In Case You Missed It: Recent CTP News
This newsletter serves as a digest of the latest announcements and stories out of CTP. It is a complement to our Spotlight on Science newsletter and CTP News e-blasts.
|
